{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:43:27Z","timestamp":1785426207676,"version":"3.56.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T00:00:00Z","timestamp":1725667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T00:00:00Z","timestamp":1725667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Zhejiang Association of Rehabilitation Medicine Scientific Research Fund","award":["ZKKY2023005"],"award-info":[{"award-number":["ZKKY2023005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pain Ther"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s40122-024-00651-0","type":"journal-article","created":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T16:02:06Z","timestamp":1725724926000},"page":"1499-1509","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Methadone Conversion Using a 3-Day Switch Strategy in Patients with Cancer on High-Dose Opioids: A Retrospective Study"],"prefix":"10.1007","volume":"13","author":[{"given":"Lei","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinfei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanai","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunfang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,7]]},"reference":[{"key":"651_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jpain.2020.04.004","volume":"22","author":"V Hanna","year":"2021","unstructured":"Hanna V, Senderovich H. Methadone in pain management: a systematic review. J Pain. 2021;22:233\u201345.","journal-title":"J Pain"},{"key":"651_CR2","volume-title":"WHO model list of essential medicines, 20th list (March 2017, amended August 2017)","author":"World Health O","year":"2017","unstructured":"World Health O. WHO model list of essential medicines, 20th list (March 2017, amended August 2017). Geneva: World Health Organization; 2017."},{"key":"651_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3109\/15360288.2014.938883","volume":"28","author":"P Good","year":"2014","unstructured":"Good P, Afsharimani B, Movva R, Haywood A, Khan S, Hardy J. Therapeutic challenges in cancer pain management: a systematic review of methadone. J Pain Palliat Care Pharmacother. 2014;28:197\u2013205.","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"651_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"651_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.currproblcancer.2018.05.002","volume":"43","author":"N Wang","year":"2019","unstructured":"Wang N, Dong Y, Zhao L, Zhao H, Li W, Cui J. Factors associated with optimal pain management in advanced cancer patients. Curr Probl Cancer. 2019;43:77\u201385.","journal-title":"Curr Probl Cancer"},{"key":"651_CR6","first-page":"4","volume":"8","author":"W Gu","year":"1999","unstructured":"Gu W, Liu Z. National surveys report on cancer pain in China. Chin J Drug Depend. 1999;8:4\u20135.","journal-title":"Chin J Drug Depend"},{"key":"651_CR7","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/S0140-6736(16)00161-6","volume":"387","author":"S Berterame","year":"2016","unstructured":"Berterame S, Erthal J, Thomas J, Fellner S, Vosse B, Clare P, et al. Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study. Lancet. 2016;387:1644\u201356.","journal-title":"Lancet"},{"key":"651_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12904-022-01076-2","volume":"21","author":"H Ding","year":"2022","unstructured":"Ding H, Song Y, Xin W, Sun J, Zhong L, Zhou Q, et al. Methadone switching for refractory cancer pain. BMC Palliat Care. 2022;21:191.","journal-title":"BMC Palliat Care"},{"key":"651_CR9","doi-asserted-by":"crossref","unstructured":"Wiffen PJ, Wee B, Moore RA. Oral morphine for cancer pain. Cochrane Database Syst Rev. 2016;4:1465\u20131858.","DOI":"10.1002\/14651858.CD003868.pub4"},{"key":"651_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1515\/sjpain-2018-0012","volume":"18","author":"ISK Thong","year":"2018","unstructured":"Thong ISK, Jensen MP, Mir\u00f3 J, Tan G. The validity of pain intensity measures: what do the NRS, VAS, VRS, and FPS-R measure? Scand J Pain. 2018;18:99\u2013107.","journal-title":"Scand J Pain"},{"key":"651_CR11","unstructured":"Health UDo, Services H. National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) v 5.0. 2017. 2023."},{"key":"651_CR12","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.4103\/IJPC.IJPC_186_17","volume":"24","author":"G Palat","year":"2018","unstructured":"Palat G, Chary S. Practical guide for using methadone in pain and palliative care practice. Indian J Palliat Care. 2018;24:S21\u20139.","journal-title":"Indian J Palliat Care"},{"key":"651_CR13","doi-asserted-by":"publisher","first-page":"536","DOI":"10.5694\/j.1326-5377.2000.tb139323.x","volume":"173","author":"OT Ayonrinde","year":"2000","unstructured":"Ayonrinde OT, Bridge DT. The rediscovery of methadone for cancer pain management. Med J Aust. 2000;173:536\u201340.","journal-title":"Med J Aust"},{"key":"651_CR14","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.jpainsymman.2016.05.022","volume":"52","author":"P Poulain","year":"2016","unstructured":"Poulain P, Berleur MP, Lefki S, Lefebvre D, Chvetzoff G, Serra E, et al. Efficacy and safety of two methadone titration methods for the treatment of cancer-related pain: the EQUIMETH2 trial (Methadone for Cancer-Related Pain). J Pain Symptom Manage. 2016;52:626-36.e1.","journal-title":"J Pain Symptom Manage"},{"key":"651_CR15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1526-4637.2012.01334.x","volume":"13","author":"S Mercadante","year":"2012","unstructured":"Mercadante S. Switching methadone: a 10-year experience of 345 patients in an acute palliative care unit. Pain Med. 2012;13:399\u2013404.","journal-title":"Pain Med"},{"key":"651_CR16","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1089\/jpm.2018.0490","volume":"22","author":"S Okayama","year":"2019","unstructured":"Okayama S, Matsuda Y, Yoshikawa Y. A comparative study of opioid switching to methadone for cancer pain control in successful and unsuccessful cases. J Palliat Med. 2019;22:844\u20137.","journal-title":"J Palliat Med"},{"key":"651_CR17","unstructured":"National Comprehensive Cancer Network. Adult Cancer Pain (Version 2. 2023)."},{"key":"651_CR18","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jpainsymman.2015.02.029","volume":"50","author":"S McLean","year":"2015","unstructured":"McLean S, Twomey F. Methods of rotation from another strong opioid to methadone for the management of cancer pain: a systematic review of the available evidence. J Pain Symptom Manage. 2015;50:248-59.e1.","journal-title":"J Pain Symptom Manage"},{"key":"651_CR19","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jpainsymman.2018.12.001","volume":"57","author":"ML McPherson","year":"2019","unstructured":"McPherson ML, Walker KA, Davis MP, Bruera E, Reddy A, Paice J, et al. Safe and appropriate use of methadone in hospice and palliative care: expert consensus white paper. J Pain Symptom Manage. 2019;57:635-45.e4.","journal-title":"J Pain Symptom Manage"},{"key":"651_CR20","first-page":"CD003971","volume":"2","author":"AB Nicholson","year":"2017","unstructured":"Nicholson AB, Watson GR, Derry S, Wiffen PJ. Methadone for cancer pain. Cochrane Database Syst Rev. 2017;2:CD003971.","journal-title":"Cochrane Database Syst Rev"},{"key":"651_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4103\/0976-500X.184773","volume":"7","author":"SJ Baumrucker","year":"2016","unstructured":"Baumrucker SJ, Jbara M, Rogers RM. A new mathematical approach to methadone conversion. J Pharmacol Pharmacother. 2016;7:93\u20135.","journal-title":"J Pharmacol Pharmacother"},{"key":"651_CR22","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1016\/j.ejca.2011.06.047","volume":"47","author":"K Moksnes","year":"2011","unstructured":"Moksnes K, Dale O, Rosland JH, Paulsen O, Klepstad P, Kaasa S. How to switch from morphine or oxycodone to methadone in cancer patients? a randomised clinical phase II trial. Eur J Cancer. 2011;47:2463\u201370.","journal-title":"Eur J Cancer"},{"key":"651_CR23","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00520-009-0649-8","volume":"18","author":"DI Cubero","year":"2010","unstructured":"Cubero DI, del Giglio A. Early switching from morphine to methadone is not improved by acetaminophen in the analgesia of oncologic patients: a prospective, randomized, double-blind, placebo-controlled study. Support Care Cancer. 2010;18:235\u201342.","journal-title":"Support Care Cancer"},{"key":"651_CR24","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1007\/s00520-013-1928-y","volume":"21","author":"S Mercadante","year":"2013","unstructured":"Mercadante S, Prestia G, Adile C, Casuccio A. Changes of QTc interval after opioid switching to oral methadone. Support Care Cancer. 2013;21:3421\u20134.","journal-title":"Support Care Cancer"},{"key":"651_CR25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1517\/14740338.6.3.289","volume":"6","author":"GB Ehret","year":"2007","unstructured":"Ehret GB, Desmeules JA, Broers B. Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology. Expert Opin Drug Saf. 2007;6:289\u2013303.","journal-title":"Expert Opin Drug Saf"}],"container-title":["Pain and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-024-00651-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40122-024-00651-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-024-00651-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T11:12:24Z","timestamp":1730977944000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40122-024-00651-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,7]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["651"],"URL":"https:\/\/doi.org\/10.1007\/s40122-024-00651-0","relation":{},"ISSN":["2193-8237","2193-651X"],"issn-type":[{"value":"2193-8237","type":"print"},{"value":"2193-651X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,7]]},"assertion":[{"value":"4 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Lei Lei, Qinfei Zhou, Xi Liu, Guanai Bao, Haiying Ding, Qunfang Ding, and Liyan Gong declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Approval for this retrospective study was obtained from the Ethics Committee of the Faculty of Zhejiang Cancer Hospital (No. IRB-2020-4). All procedures complied with the Ethical Standards of the Institutional and\/or National Research Committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was waived by the Medical Ethics Committee of Zhejiang Cancer Hospital due to the retrospective nature of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}